SUMMARY The activity of urea cycle enzymes was assayed in duodenal biopsy specimens obtained from a female infant who presented with neonatal hyperammonaemia. All enzyme levels were normal except N-acetyl glutamate-dependent carbamyl phosphate synthetase 1 (CPS1) which was half the mean activity in normal control specimens. A similar deficiency of CPSl was also shown in duodenal specimens from the patients's mother who became slightly symptomatic after relatively high protein meals and during pregnancy, and had spontaneously modified her diet to one with protein restriction. The patient is growing normally on a dietary regimen similar to that spontaneously adopted by her mother. Urea cycle enzyme activity in the duodenal biopsy material from the controls was similar to that found in the normal human liver and appears to have distinct advantages as a means of assaying for urea generalised increase in urinary amino-acids, particularly glycine. Urinary proline and glutamine were also raised with slight increase in ornithine. There was no change in the infant's convulsions after phenobarbitone, and IV diazepam and then phenytoin achieved only partial and temporary control. There was no apparent response to pyridoxine. After 48 hours of repetitive minor convulsions the infant was begun on oral glucose feeds and seizures stopped 12 hours later, only to reappear shortly after reinstituting breast feeding, which resulted in plasma ammonia rising to 100 Ftg/ml (5543 ,Lmol/l). Convulsions again stopped within 6 hours of reinstituting glucose feeds. Low protein intake was instituted and on 0 86 g of protein/kg per day her plasma ammonia was slightly raised at 57 tg/ml (3160 [Lmol/l), with persisting increases in plasma glutamine and proline. The high fat and low protein intake during the first year produced pronounced obesity with some stunting of length.
Her growth pattern returned to normal after gradual increase in protein intake to 1 * 2 g/kg per day. Plasma ammonia remained marginally raised (65-71 ,g/ml; 3603-3936 ,umol/l) with persisting high levels of glutamine, alanine, and glycine and marginally increased proline, ornithine, and aspartic acid. Serum aspartate amino transferase and galactose-l-phosphate uridyl transferase levels were normal both at 2 years and 4j years. Prothrombin and kaolin clotting time were slightly prolonged in both the patient and mother before each bowel biopsy. These coagulation defects were responsive to parenteral administration of vitamin K.
The child, now aged 4j years, is a pleasant intelligent child who is growing normally. Her height 101 3 cm is on the 50th centile and weight 15.5 kg just below the 30th centile. Protein is included with every meal and she now drinks 100 to 200 ml milk per day. Plasma ammonia on her present diet is 15 .tg/ml; 831 ,umol/l (normal range 4-49 ,g/ml; 222-2716 ,umol/l).
The mother's history proved to be of much interest. with the level of activity normally found in the liver ( Table 2 ). As shown, the patient had low levels of CPS1 on both occasions the enzyme was measured, the level being approximately half that found in the controls (Table 1 ). The level of CPSl in the mother was similar to that of the patient and likewise showed about half normal activity. Human duodenal mucosa was found to have high levels of all urea cycle enzymes ( Table 2 ). Upper small intestine appeared to have about half the level of CPS1 activity found in the liver, whereas the OTC activity was comparable. The arginosuccinate synthetase and arginosuccinate lyase activities were much higher in the duodenum than in human liver, and arginase activities appeared to be lower. A portion of one specimen from the first procedure on the patient and also from the mother were shown to be histologically normal and contained normal levels of lactase, sucrase, and maltase. Discussion CPS1 deficiency is a fairly rare genetic defect. A study on 6 related subjects with the defect shows an autosomal recessive inheritance pattern. 3 Although the findings on patients reported with this disorder vary,' a common feature is hyperammonaemia associated with the intake of normal levels of protein, episodic motor impairment and seizures, and a generalised disturbance in amino-acid metabolism. The extent of CPS1 deficiency also varies considerably, and an almost complete lack of CPS1 has been reported in only one patient, who died at age 3 days.10 The 2 cases reported here show a less severe form of the defect, and the child, who was shown to be protein-intolerant had raised urine glycine levels, as did the patients of Freeman et CPS1 is a highly labile enzyme, the activity in liver samples may be affected by compounds produced during the neonatal hepatitis which may accompany hyperammonaemia. Intestinal biopsies will avoid this complication, and the normality of the biopsy sample can readily be verified by histological analysis and disaccharidase assay. It should also be stressed that the early diagnosis of this disorder is important if intellectual impairment is to be avoided, since mental retardation is common in all the CPS1 defects reported to date, 1 3and is apparently absent in the two cases reported in this paper. Hyperammonaemia has been reported to be associated with defects in short-chain fatty acid metabolism,'1'6 and we have found both CPS1 and OTC activities to be reduced in a patient with raised urine 3-methyl glutaric, 3-methyl glutaconic, and 3-hydroxy, 3-methyl glutaric acids (unpublished). Similarly, hyperammonaemia and CPS1 and OTC deficiencies may be associated with Reye's syndrome.'7-'8 However, these other causes of hyperammonaemia were ruled out since OTC was normal and only CPS1 was reduced in activity; this reduction being noted both during the hyperammonaemic crisis and on subsequent measurement when the patient was well. In addition, no abnormal urine organic acid pattern emerged on gas-liquid chromatography of urine.
An unusual finding in the present cases was the vitamin K-responsive coagulation defects observed in both the mother and daughter, when there was no other apparent evidence of disturbed hepatocyte function. This observation, which suggests a link between the CPSl lesion and vitamin K metabolism, appears to warrant further exploration.
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